Leaderboards/Pediatric Hepatobiliary Diseases and Treatments

Pediatric Hepatobiliary Diseases and Treatments

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Rūta Kučinskienė
Lithuanian University of Health Sciences
99
2
Endale Gebreegziabher Gebremedhn
University of Gondar
65
3
Gao‐Jun Teng
Zhongda Hospital Southeast University
54
4
Ashley Lucien Joseph D. Cruz
Narayana Health
50
5
Ümit Çelik
Adana Numune Eğitim ve Araştırma Hastanesi
50
6
Rodolfo Mattar Rosa
University of Córdoba
50
7
A. Jay Freeman
Nationwide Children's Hospital
50
8
Wayne Smith
Virginia Commonwealth University Medical Center
50
9
Takahiro Namba
Cedars-Sinai Medical Center
50
10
Olubunmi Fatoki
Texas A&M Health Science Center
50

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Gebrehiwot Asfaw
Bahir Dar University
99
2
Xiaowen Song
Zhongda Hospital Southeast University
81
3
María Ángeles Puche-Larrubia
Instituto Maimónides de Investigación Biomédica de Córdoba
50
4
Grace R. Paul
Nationwide Children's Hospital
50
5
Manjuladevi E.
Government Medical College and Hospital
50
6
A. R. Gaifutdinova
Kazan State Medical University
50
7
Oriana Boscolo
University of Buenos Aires
50
8
Bailey Hamner
Michigan Medicine
50
9
Nikolai Aksenov
Texas A&M Health Science Center
50
10
Shintaro Fujiwara
Okayama Medical Center
50

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
David N. Assis
Yale University
99
2
Saul J. Karpen
Karolinska University Hospital
95
3
Hidefumi Hiramatsu
Kyoto University
90
4
Stefan G. Hübscher
Queen Elizabeth Hospital Birmingham
89
5
Gregory Wong
Chinese Journal of Integrated Traditional and Western Medicine
88
6
Anton LeMair
World Allergy Organization
87
7
Ofelia Álvarez
University of Miami
82
8
Natasha Corbitt
Southwestern Medical Center
81
9
Al B. Benson
Northwestern University
79
10
Alessandra Franco
University of California San Diego
72

All-Time Leaders Papers

1
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2017
1.4k cit.
2
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
Journal of the National Comprehensive Cancer Network|2018
1k cit.
3
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2018
990 cit.
4
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
808 cit.
5
NCCN Guidelines Insights: Rectal Cancer, Version 6.2020
Journal of the National Comprehensive Cancer Network|2020
498 cit.
6
Interleukin-1β-mediated Suppression of RXR:RAR Transactivation of the Ntcp Promoter Is JNK-dependent
Journal of Biological Chemistry|2002
119 cit.
7
The Role of Macrophage Migration Inhibitory Factor in Autoimmune Liver Disease
Hepatology|2013
106 cit.
8
Inflammatory Mediators Increase SUMOylation of Retinoid X Receptor α in a c-Jun N-Terminal Kinase–Dependent Manner in Human Hepatocellular Carcinoma Cells
Molecular Pharmacology|2013
22 cit.

Reagents for Pediatric Hepatobiliary Diseases and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

NUP98 (C39A3) Rabbit Monoclonal Antibody (Alexa Fluor® 555 Conjugate)

#20280$465
View Evidence →Cell Signaling Technology

FastScan™ Total GSK-3 alpha ELISA Kit

#74929$678
View Evidence →Proteintech

Cytokeratin 19 antibody

#10712-1-AP$449
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Phospho-BLNK (Thr152) (E4P2P) Rabbit Monoclonal Antibody

#62144$176
View Evidence →Cell Signaling Technology

CDX2 (D11D10) Rabbit Monoclonal Antibody

#12306$160
View Evidence →Cell Signaling Technology

Pan-Keratin (C11) Mouse Monoclonal Antibody (mFluor™ UV375 Conjugate)

#80988$465
View Evidence →